Abstract
Elevated heart rate (HR) is an independent risk factor for cardiovascular outcomes in various cardiac diseases, including heart failure (HF). Randomized placebo-controlled study was conducted to evaluate the effects of ivabradine, an Ifinhibitor, on the resting HR in 126 Japanese symptomatic HF patients with left ventricular ejection fraction ≤35%, resting HR ≥75 beats/min in sinus rhythm, and stable, optimal background treatment. Patients were randomly allocated into 3 groups: placebo; starting dose of ivabradine 2.5 mg twice daily (BID; 2.5 mg group); 5 mg BID group. The dose was increased up to 7.5 mg BID according to dose-adjustment criteria. After the 6-week treatment, the reductions in resting HR were significant in both the 2.5-mg (16.6±8.1 beats/min) and 5-mg (16.4±9.6 beats/min) groups (P<0.0001 for both groups) compared with placebo (1.7±8.7 beats/min). The most frequent side effect of ivabradine was phosphenes, but all were mild. Treatment was discontinued in 1 patient due to HF in the 5 mg group. Ivabradine starting at 2.5 or 5 mg BID effectively reduced resting HR in Japanese HF patients. Ivabradine at the starting dose of 2.5 mg BID could be safer than 5 mg BID. (Circ J 2016; 80: 668-676).
References
Nov 1, 1992·Journal of the American College of Cardiology·J A PanzaA A Quyyumi
Jun 1, 1987·American Heart Journal·W B KannelL A Cupples
Dec 1, 1996·Circulation·W S ColucciM A Lukas
Sep 26, 2001·Circulation·U E Heidland, B E Strauer
Jul 24, 2004·Circulation Research·Joanne S Ingwall, Robert G Weiss
Feb 3, 2006·International Journal of Clinical Practice·S Sulfi, A D Timmis
Dec 11, 2007·International Journal of Cardiology·George D GiannoglouGeorge E Louridas
Jun 3, 2009·Annals of Internal Medicine·Finlay A McAlisterPaul W Armstrong
Aug 31, 2010·Lancet·Karl SwedbergUNKNOWN SHIFT Investigators
Aug 31, 2011·European Heart Journal·Jean-Claude TardifUNKNOWN SHIFT Investigators
Aug 31, 2011·European Heart Journal·Inger EkmanKarl Swedberg
May 12, 2012·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Michael BöhmLuigi Tavazzi
May 24, 2012·Journal of the American College of Cardiology·Karl SwedbergUNKNOWN SHIFT Investigators
Aug 29, 2012·European Heart Journal·Jeffrey S BorerUNKNOWN SHIFT Investigators
May 23, 2013·European Journal of Heart Failure·Jan-Christian ReilMichael Böhm
Jun 28, 2013·European Journal of Heart Failure·Luigi TavazziUNKNOWN SHIFT Investigators
Sep 26, 2013·Drugs·Prakash Deedwania
Nov 15, 2013·International Journal of Cardiology·L TavazziUNKNOWN SHIFT Investigators
Dec 18, 2013·The American Journal of Cardiology·Jeffrey S BorerUNKNOWN SHIFT Investigators
Feb 8, 2014·European Journal of Heart Failure·Adriaan A VoorsUNKNOWN SHIFT investigators
Jun 26, 2014·European Journal of Heart Failure·Michel KomajdaUNKNOWN SHIFT Investigators
Feb 24, 2015·Advances in Therapy·A E BagriyE A Bagriy
Apr 17, 2015·Circulation Journal : Official Journal of the Japanese Circulation Society·Michel Komajda
May 15, 2015·Cardiology·Edimar Alcides BocchiUNKNOWN SHIFT investigators
Sep 12, 2015·Circulation Journal : Official Journal of the Japanese Circulation Society·Ryoichi UshigomeUNKNOWN CHART-2 Investigators
Citations
Jan 30, 2016·Circulation Journal : Official Journal of the Japanese Circulation Society·Tetsu Watanabe
Aug 23, 2016·Circulation Journal : Official Journal of the Japanese Circulation Society·Barry Greenberg
Nov 9, 2016·Journal of Immunology Research·Ilonka RohmAtilla Yilmaz
Jul 27, 2018·Circulation Journal : Official Journal of the Japanese Circulation Society·Hiroyuki TsutsuiWeinong Guo
Aug 9, 2019·Circulation Journal : Official Journal of the Japanese Circulation Society·Hiroyuki TsutsuiUNKNOWN J-SHIFT Study Investigators
Jul 20, 2018·Journal of General Internal Medicine·Peysh A PatelKlaus K Witte
Jul 17, 2019·International Heart Journal·Hui PeiZhuo Zhao
Sep 3, 2018·International Journal of Clinical Pharmacy·Camila HartmannCristina Pellegrino Baena
Jan 5, 2019·Circulation Journal : Official Journal of the Japanese Circulation Society·Tomomi IdeHiroyuki Tsutsui
Oct 6, 2018·Chonnam Medical Journal·Han Byul KimMyung Ho Jeong
Feb 1, 2020·Medicine·Heng LiLiming Lu
Nov 5, 2020·The Cochrane Database of Systematic Reviews·Carina BenstoemVincent Brandenburg
Nov 9, 2020·Clinical Therapeutics·Hongbing WanQinghua Wu
Feb 28, 2021·Clinical Cardiology·Sasmita Bryan RichardSuxin Luo
Jul 20, 2021·International Heart Journal·Teruhiko Imamura, Koichiro Kinugawa
Oct 13, 2021·Canadian Journal of Physiology and Pharmacology·Noémi TóthNorbert Nagy